Service Navigation

OTC derivatives regulation

OTC derivatives regulation

As a result of the turbulences caused by the global financial crisis, regulators worldwide increasingly focus on derivatives markets. Given the enormous risks posed by the unregulated off-exchange (“over the counter”/OTC-) market, there is a growing recognition that greater transparency in exchange trading significantly contributes to the future stability of the international financial markets.

At their 2009 summit in Pittsburgh, the G20 member heads of state and government came to the agreement that, by the end of 2012, all standardised derivatives contracts will have to be traded through exchanges or electronic trading platforms. In addition, large parts of OTC trading will have to be settled on a collateralised basis and reported to central trade repositories.

Within the European Union, this objective has already been implemented through the European Market Infrastructure Regulation (EMIR). Deutsche Börse Group meets these new regulatory requirements and is adapting its product offering accordingly, thus continuing to provide secure and transparent solutions to its customers and strengthening the stability of the financial markets.